Abstract：
BACKGROUND: Robot-assisted nephrectomy for living kidney donation (LKD) has been described in the literature as a safe and reproducible technique in high volume centers with extensive robotic surgery experience. Any surgical procedure in a healthy individual ought to be safe in regards to complications. The objective of this study was to evaluate the Robotic-assisted Living Donor Nephrectomy (RLDN) experience in a robotic surgery expert center.
METHODS: This is a retrospective study from 11/2011 and 12/2019. In total, 118 consecutive Living Donor (LD) kidney transplants were performed at our institution. All the procedures were performed by robotic-assisted laparoscopic approach. Extraction was performed by iliac (IE), vaginal (VE) or umbilical extraction (UE). The left kidney was preferred even if the vascular anatomy was not modal.
RESULTS: For donors: the median operative time was 120min with 50mL of blood loss. The median warm ischemia time was 4min, with a non-significant shorter duration with the UE (4min) in comparison with IE or VE (5min). Nine patients had postoperative complications including 1 grade II (blood transfusion) and 1 grade IIIb (vaginal bleeding after VE). None of our procedures were converted to open surgeries and no deaths were reported. For the recipients: 1.7% presented delayed graft function; their median GFR at 1 year was 61mL/min/1.73m2.
CONCLUSIONS: RLDN in an expert center appears to be a safe technique. The advantages of the robot device in terms of ergonomy don\'t hamper the surgical outcomes. Donor, recipient and graft survivals seem comparable to the reported laparoscopic outcomes in the literature.
METHODS:
METHODS: This is a retrospective study from 11/2011 and 12/2019. In total, 118 consecutive Living Donor (LD) kidney transplants were performed at our institution. All the procedures were performed by robotic-assisted laparoscopic approach. Extraction was performed by iliac (IE), vaginal (VE) or umbilical extraction (UE). The left kidney was preferred even if the vascular anatomy was not modal.
RESULTS: For donors: the median operative time was 120min with 50mL of blood loss. The median warm ischemia time was 4min, with a non-significant shorter duration with the UE (4min) in comparison with IE or VE (5min). Nine patients had postoperative complications including 1 grade II (blood transfusion) and 1 grade IIIb (vaginal bleeding after VE). None of our procedures were converted to open surgeries and no deaths were reported. For the recipients: 1.7% presented delayed graft function; their median GFR at 1 year was 61mL/min/1.73m2.
CONCLUSIONS: RLDN in an expert center appears to be a safe technique. The advantages of the robot device in terms of ergonomy don\'t hamper the surgical outcomes. Donor, recipient and graft survivals seem comparable to the reported laparoscopic outcomes in the literature.
METHODS:
摘要：
背景：文献中已经描述了用于活体肾脏捐献（LKD）的机器人辅助肾切除术在具有广泛机器人手术经验的高容量中心是一种安全且可重复的技术。健康个体的任何外科手术在并发症方面都应该是安全的。这项研究的目的是评估机器人辅助活体供体肾切除术（RLDN）在机器人手术专家中心的经验。
方法：这是一项2011年11月和2019年12月的回顾性研究。总的来说,我们机构连续进行了118例活体捐献者（LD）肾脏移植。所有手术均通过机器人辅助腹腔镜方法进行。通过髂(IE)进行提取，阴道（VE）或脐带提取（UE）。即使血管解剖结构不是模态的，左肾也是首选。
结果：对于供体：中位手术时间为120min，失血量为50mL。中位热缺血时间为4min，与IE或VE(5min)相比,UE具有非显著较短的持续时间(4min)。9例患者发生术后并发症，包括1个II级（输血）和1个IIIb级（VE后阴道出血）。我们的手术均未转换为开放式手术，也没有死亡报告。对于接受者：1.7％的人表现出延迟的移植物功能；他们在1年时的中位GFR为61mL/min/1.73mL。
结论：专家中心的RLDN似乎是一种安全的技术。机器人设备在人体工程学方面的优势不会妨碍手术结果。捐助者,受者和移植物存活率似乎与文献中报道的腹腔镜结局相当.
方法：
方法：这是一项2011年11月和2019年12月的回顾性研究。总的来说,我们机构连续进行了118例活体捐献者（LD）肾脏移植。所有手术均通过机器人辅助腹腔镜方法进行。通过髂(IE)进行提取，阴道（VE）或脐带提取（UE）。即使血管解剖结构不是模态的，左肾也是首选。
结果：对于供体：中位手术时间为120min，失血量为50mL。中位热缺血时间为4min，与IE或VE(5min)相比,UE具有非显著较短的持续时间(4min)。9例患者发生术后并发症，包括1个II级（输血）和1个IIIb级（VE后阴道出血）。我们的手术均未转换为开放式手术，也没有死亡报告。对于接受者：1.7％的人表现出延迟的移植物功能；他们在1年时的中位GFR为61mL/min/1.73mL。
结论：专家中心的RLDN似乎是一种安全的技术。机器人设备在人体工程学方面的优势不会妨碍手术结果。捐助者,受者和移植物存活率似乎与文献中报道的腹腔镜结局相当.
方法：
